We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLMA icon
276
Olema Pharmaceuticals
OLMA
$1.01B
$196K 0.09%
7,114
-365
-5% -$9.85K
RLAY icon
277
Relay Therapeutics
RLAY
$3.99B
$196K 0.09%
6,213
-331
-5% -$11.1K
QURE icon
278
uniQure
QURE
$2.52B
$195K 0.09%
6,087
-324
-5% -$9.88K
ACIU icon
279
AC Immune
ACIU
$236M
$193K 0.08%
28,694
-1,493
-5% -$10.7K
VXRT
280
DELISTED
Vaxart
VXRT
$193K 0.08%
24,331
-1,258
-5% -$10.4K
ALBO
281
DELISTED
Albireo Pharma Inc
ALBO
$193K 0.08%
6,197
-326
-5% -$10.1K
PRAX icon
282
Praxis Precision Medicines
PRAX
$8.25B
$190K 0.08%
684
-36
-5% -$9.77K
ARNA
283
DELISTED
Arena Pharmaceuticals Inc
ARNA
$189K 0.08%
3,178
-172
-5% -$10.2K
XBIT icon
284
XBiotech
XBIT
$69.2M
$187K 0.08%
14,424
+1,078
+8% +$17.2K
PMVP icon
285
PMV Pharmaceuticals
PMVP
$58.7M
$186K 0.08%
6,229
-327
-5% -$10.4K
XNCR icon
286
Xencor
XNCR
$1.48B
$186K 0.08%
5,691
-301
-5% -$9.89K
AMRS
287
DELISTED
Amyris Inc.
AMRS
$186K 0.08%
13,580
-704
-5% -$10.1K
MGTX icon
288
MeiraGTx Holdings
MGTX
$1.09B
$185K 0.08%
14,007
-729
-5% -$9.98K
NUVB icon
289
Nuvation Bio
NUVB
$2.33B
$185K 0.08%
18,640
-964
-5% -$8.74K
TGTX icon
290
TG Therapeutics
TGTX
$8.4B
$185K 0.08%
5,549
-291
-5% -$9K
MORF
291
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$185K 0.08%
3,273
-169
-5% -$10.2K
CRSP icon
292
CRISPR Therapeutics
CRSP
$4.68B
$184K 0.08%
1,644
-93
-5% -$11.7K
IMGN
293
DELISTED
Immunogen Inc
IMGN
$183K 0.08%
32,252
-1,691
-5% -$9.77K
REPL icon
294
Replimune Group
REPL
$449M
$182K 0.08%
6,134
-318
-5% -$10.3K
TPTX
295
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$182K 0.08%
2,735
-145
-5% -$10.3K
TBPH icon
296
Theravance Biopharma
TBPH
$875M
$181K 0.08%
24,402
-2,241
-8% -$25.1K
LITS
297
Lite Strategy Inc
LITS
$33M
$179K 0.08%
3,241
-169
-5% -$9.3K
RNAC icon
298
Cartesian Therapeutics
RNAC
$225M
$177K 0.08%
1,414
-74
-5% -$8.94K
RLMD icon
299
Relmada Therapeutics
RLMD
$549M
$176K 0.08%
6,703
-353
-5% -$9.45K
XENE icon
300
Xenon Pharmaceuticals
XENE
$6.28B
$176K 0.08%
11,494
-597
-5% -$10.4K
10 11
12
13 14

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.